This is consistent with the upregulation of many DNA damage response genes in GSCs, including PARP1 (12), that corresponds to poorer overall survival in both high-grade GBM (Supplementary Figure S1C) and grade III GBM (Supplementary Figure S1D). The gene discussed is PARP1; the disease is glioblastoma.